EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One‐Year Outcomes From a Prospective Observational Study

Yongwen Zhou iD, Ying Ni iD, Hongrong Deng, Qiongyan Lin, Mengyun Lei iD, Ziqing Lin, Daizhi Yang iD, Yanli Cao, Yu Zhao, Benjamin John Wheeler, Xubin Yang iD, Wen Xu iD und 1 weitere

Diabetes, Obesity and Metabolism · 2026-12 · 28 (12) · 11545-11555

DOI: 10.1111/dom.71347 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, online erschienen am 17.09.2026. Verfasst von Yongwen Zhou und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diabetolo…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Hypoglycemic Agents, Insulin Infusion Systems. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology Major Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study aims to evaluate the effectiveness and safety of early AID initiation combined with a telehealth support programme in individuals recently diagnosed with type 1 diabetes (T1D) in mainland China. Materials and Methods This prospective, single‐arm, observational study sequentially enrolled individuals within 3 months of T1D diagnosis who initiated self‐funded AID system with the AndroidAPS algorithm. Participants received a structured e‐learning and personalised telehealth consultation during the first month followed by regular virtual follow‐up. Glycaemic outcomes were assessed at 1, 3, 6, and 12 months after AID initiation. Safety outcomes included severe hypoglycaemia (SH) and diabetic ketoacidosis (DKA).

Results

A total of 126 participants completed at least 3 months of follow‐up. Median age was 13.6 (8.9, 27.4) years and median diabetes duration was 0.9 (0.5, 1.7) months. Percentage of time in range 3.9–10.0 mmol/L (TIR) was 85.2% (80.4, 90.7) during the first month and remained stable through 12 months. Among individuals with prior CGM data ( N = 93), TIR increased from 70.0% (58.6, 80.2) before AID initiation to 84.8% (79.9, 90.4) at 1 month and remained similar at 12 months. HbA1c (when available, n = 95) decreased from 10.0% (8.0, 13.4) [86 mmol/mol (64, 123)] at diagnosis to 6.3% (6.0, 6.8) [45 mmol/mol (42, 51)] at 12 months. No episodes of SH or DKA were reported. However, by the latest data update (August, 2026), the AID discontinuation rate was 35.7% ( N = 45), which was mainly due to financial barriers (55.2%).

Conclusions

Early self‐funded AID initiation, supported by telehealth support, was associated with rapid and sustained glycaemic improvement in those recently diagnosed with T1D. Financial burden was the key challenge for consistent use of this advanced diabetes technology. Trail Registration NCT06081231.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinHypoglycemic AgentsInsulin Infusion SystemsHumansFemaleProspective StudiesTelemedicineMaleAdultAdolescentYoung AdultDiabetic KetoacidosisChildHypoglycemiaTreatment OutcomeChinaBlood GlucoseBlood Glucose Self-Monitoring

Stichwörter der Autor:innen

automated insulin deliveryearly diagnosisefficacytelehealthtype 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood Glucose

Autor:innen und Institutionen

  • Department of Endocrinology and Metabolism, The Third Affiliated Hospital of Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, China.
  • Department of Endocrinology, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Department of Endocrinology and Metabolism, Institute of Endocrinology, NHC Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Affiliated Hospital of China Medical University, Shenyang, People's Re…
  • Department of Endocrinology, Affiliated Hospital Group of Guangdong Medical University Shenzhen Baoan Central Hospital (Baoan Central Hospital of Shenzhen), Shenzhen, Guangdong, China.
  • Department of Paediatrics and Child Health, Faculty of Medicine - Dunedin, University of Otago, Dunedin, New Zealand.

ORCID-Profile: Yongwen Zhou, Ying Ni, Mengyun Lei, Daizhi Yang, Xubin Yang, Wen Xu, Jinhua Yan

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology Major Project

Zitieren

APA

Zhou, Y., Ni, Y., Deng, H., Lin, Q., Lei, M., Lin, Z., Yang, D., Cao, Y., Zhao, Y., Wheeler, B. J., Yang, X., Xu, W., & Yan, J. (2026). Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One‐Year Outcomes From a Prospective Observational Study. Diabetes, Obesity and Metabolism, 28(12), 11545-11555. https://doi.org/10.1111/dom.71347

Vancouver

Zhou Y, Ni Y, Deng H, Lin Q, Lei M, Lin Z, et al. Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One‐Year Outcomes From a Prospective Observational Study. Diabetes, Obesity and Metabolism. 2026;28(12):11545-11555. doi:10.1111/dom.71347

BibTeX
@article{Zhou2026,
  author = {Zhou, Yongwen and Ni, Ying and Deng, Hongrong and Lin, Qiongyan and Lei, Mengyun and Lin, Ziqing and Yang, Daizhi and Cao, Yanli and Zhao, Yu and Wheeler, Benjamin John and Yang, Xubin and Xu, Wen and Yan, Jinhua},
  title = {Early Use of Automated Insulin Delivery With Telehealth Support in People Recently Diagnosed With Type 1 Diabetes: One‐Year Outcomes From a Prospective Observational Study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2026},
  volume = {28},
  number = {12},
  pages = {11545--11555},
  doi = {10.1111/dom.71347}
}
Kostenlos starten →